ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

13 links0 made here, not in the record23 judgments2 judges (the rules as one: Rule based)0 record changes seen
Claude Opus 5.5Rule based
Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT03784014Molecular Profiling ofAdvanced Soft-tissueSarcomasInstitut National de la Santé Phase 3 · completedRECORDThe record itselfVersions seen nightly since Sep 25, 2…›No new version seen since tracking began Sep 25, 2026.CONDITIONSSarcomaThe registry's MeSH filing›As of now · Rule based · Main conditionMain conditionNeoplasm MetastasisThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.DRUGSNilotinibIntervention entry›Nov 3 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · BackgroundBackgroundCeritinibIntervention entry›Nov 3 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · BackgroundBackgroundCapmatinibIntervention entry›Nov 3 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · BackgroundBackgroundLapatinibIntervention entry›Nov 3 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · BackgroundBackgroundTrametinibIntervention entry›Nov 3 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · BackgroundBackgroundDabrafenibEntry “Trametinib and Dabrafenib”, re…›Nov 3 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · BackgroundBackgroundOlaparibEntry “Olaparib and Durvalumab”, read…›Nov 3 · Claude Opus 5.5 · Background · optionNov 18 · Rule based · BackgroundBackground · optionDurvalumabEntry “Olaparib and Durvalumab”, read…›Nov 3 · Claude Opus 5.5 · Background · optionNov 18 · Rule based · BackgroundBackground · optionPalbociclibIntervention entry›Nov 3 · Claude Opus 5.5 · Background · optionNov 18 · Rule based · BackgroundBackground · optionGlasdegibIntervention entry›Nov 3 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · BackgroundBackgroundFutibatinibEntry “TAS-120”, read by our name rule›Nov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTested

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Nilotinib

From the registry record2 judgments on this link
Role in the study, from the registry to what was judged
RegistryEntry “Nilotinib”the record gives no role
→judged=agrees
How the 2 judgments split100%of judgments with a known value say Background
Background · 2

All judgments on this study

WhenLinkJudgeDecisionState
Nov 3NilotinibClaude Opus 5.5BackgroundCurrent
Nov 3CeritinibClaude Opus 5.5BackgroundCurrent
Nov 3CapmatinibClaude Opus 5.5BackgroundCurrent
Nov 3LapatinibClaude Opus 5.5BackgroundCurrent
Nov 3TrametinibClaude Opus 5.5BackgroundCurrent
Nov 3DabrafenibClaude Opus 5.5BackgroundCurrent
Nov 3OlaparibClaude Opus 5.5Background · optionCurrent
Nov 3DurvalumabClaude Opus 5.5Background · optionCurrent
Nov 3PalbociclibClaude Opus 5.5Background · optionCurrent
Nov 3GlasdegibClaude Opus 5.5BackgroundCurrent
Nov 3FutibatinibClaude Opus 5.5TestedCurrent
Nov 18NilotinibRule based · role ruleBackgroundAgrees
Nov 18CeritinibRule based · role ruleBackgroundAgrees
Nov 18CapmatinibRule based · role ruleBackgroundAgrees
Nov 18LapatinibRule based · role ruleBackgroundAgrees
Nov 18TrametinibRule based · role ruleBackgroundAgrees
Nov 18DabrafenibRule based · role ruleBackgroundAgrees
Nov 18OlaparibRule based · role ruleBackgroundAgrees
Nov 18DurvalumabRule based · role ruleBackgroundAgrees
Nov 18PalbociclibRule based · role ruleBackgroundAgrees
Nov 18GlasdegibRule based · role ruleBackgroundAgrees
Nov 18FutibatinibRule based · role ruleTestedAgrees
As of nowSarcomaRule based · main-condition ruleMain conditionCurrent

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.

What a study is mainly about

Starts from the first condition ClinicalTrials.gov files the study under. It moves to a narrower one only when the study's own title or listed conditions name it, and sets aside terms the registry often files by mistake. A study open to many cancers is not placed under one of them unless its title names it.

Checked against studies judged one by one; the study page says when it differs from the registry.